Of note, we previously reported that basal hematopoiesis was normal in these mice when Osx-Cre was activated on day 1–2 after birth.[12] In control mice, treatment with a single dose of 5-FU induced neutropenia with a nadir on day 7 and complete recovery by day 9 (Fig 4A). Here, SP7 is linked to neutropenia.